Video

Dr. Spaggiari on Considerations for Patients With CRC and Liver Metastases Without Surgical Options

Mario Spaggiari, MD, discusses considerations for patients with colorectal cancer and liver metastases who have no surgical options.

Mario Spaggiari, MD, transplant surgeon, Division of Transplantation, University of Illinois Health, discusses considerations for patients with colorectal cancer (CRC) and liver metastases who have no surgical options.

Some patients with CRC and liver metastases are not considered to be surgical candidates, Spaggiari says. For example, a patient in which no segment of their liver can be spared would not be considered candidates for surgery.

However, advances in the field are increasing potential options for these patients, Spaggiari explains. For example, patients may be eligible for a hepatic artery infusion pump, which is an aggressive, liver-targeted chemotherapy. In approximately half of patients, this strategy downstages the tumor so the patient becomes eligible for surgery.

Ultimately, however, early utilization of chemotherapy is necessary in these situations because aggressive surgery does not work for patients who have disease progression on chemotherapy, Spaggiari concludes.

Related Videos
Viktor Grünwald, MD, PhD
Aaron Gerds, MD
Christine M. Lovly, MD, PhD, Ingram Associate Professor of Cancer Research, associate professor, medicine (hematology/oncology), Vanderbilt-Ingram Cancer Center
Haeseong Park, MD, MPH
David L. Porter, MD
Timothy Yap, MBBS, PhD, FRCP
Leo I. Gordon, MD, Abby and John Friend Professor of Oncology Research, professor, medicine (hematology and oncology), Feinberg School of Medicine, Robert H. Lurie Cancer Center
Hetty E. Carraway, MD, MBA, staff associate professor, Department of Medicine, School of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; member, Immune Oncology Program, Case Comprehensive Cancer Center; vice chair, Strategy and Enterprise Development, Taussig Cancer Institute, Division of Hematologic Oncology and Blood Disorders, Cleveland Clinic
David A. Braun, MD, PhD, assistant professor, medicine (medical oncology), Louis Goodman and Alfred Gilman Yale Scholar, member, Center of Molecular and Cellular Oncology, Yale Cancer Center
Julia Foldi, MD, PhD